The store will not work correctly when cookies are disabled.
N,N-dimethyl-2-(6-m-tolyl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide
ID: ALA4474982
PubChem CID: 124176288
Max Phase: Preclinical
Molecular Formula: C18H19N3O
Molecular Weight: 293.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)c1
Standard InChI: InChI=1S/C18H19N3O/c1-13-5-4-6-14(9-13)15-10-17-16(19-11-15)7-8-21(17)12-18(22)20(2)3/h4-11H,12H2,1-3H3
Standard InChI Key: XIIQHMZCKCZFDP-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
41.2378 -1.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2367 -2.8171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9448 -3.2260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9430 -1.5887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.6516 -1.9939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6564 -2.8126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4364 -3.0610 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9138 -2.3959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4287 -1.7365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6934 -3.8367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4938 -4.0020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7508 -4.7777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.0370 -3.3915 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.2075 -5.3881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.5511 -4.9429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5287 -3.2251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8229 -2.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1154 -3.2219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1143 -4.0399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8266 -4.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5313 -4.0392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8289 -5.2661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 293.37 | Molecular Weight (Monoisotopic): 293.1528 | AlogP: 3.10 | #Rotatable Bonds: 3 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.34 | CX LogP: 2.74 | CX LogD: 2.74 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: -1.87 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |